Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.8563
+0.0174 (2.07%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Senti Biosciences Employees
Senti Biosciences had 34 employees as of December 31, 2024. The number of employees decreased by 14 or -29.17% compared to the previous year.
Employees
34
Change (1Y)
-14
Growth (1Y)
-29.17%
Revenue / Employee
$647
Profits / Employee
-$1,807,000
Market Cap
26.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 34 | -14 | -29.17% |
| Dec 31, 2023 | 48 | -74 | -60.66% |
| Dec 31, 2022 | 122 | 33 | 37.08% |
| Dec 31, 2021 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Plus Therapeutics | 28 |
| Boundless Bio | 28 |
| Passage Bio | 24 |
| ABVC BioPharma | 19 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| Serina Therapeutics | 13 |
SNTI News
- 3 days ago - Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies - GlobeNewsWire
- 8 days ago - Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 12 days ago - Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference - GlobeNewsWire
- 4 weeks ago - Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 6 weeks ago - Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development - GlobeNewsWire
- 7 weeks ago - Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - GlobeNewsWire
- 2 months ago - Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - GlobeNewsWire